Retinoic acid for redifferentiation of thyroid cancer–does it hold its promise?
T Grüning, C Tiepolt, K Zöphel, J Bredow… - European Journal of …, 2003 - academic.oup.com
Objectives To evaluate the effectiveness of isotretinoin for improving 131I uptake in
recurrent/metastasized thyroid cancer with no/insufficient 131I uptake. Design Retrospective …
recurrent/metastasized thyroid cancer with no/insufficient 131I uptake. Design Retrospective …
Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?
E Hindié, D Mellière, F Lange, I Hallaj… - European journal of …, 2003 - Springer
Functioning pulmonary metastases are the most common distant lesions of differentiated
thyroid cancer. About 50% of patients with such metastases die within 10 years. The impact …
thyroid cancer. About 50% of patients with such metastases die within 10 years. The impact …
[HTML][HTML] Indium-111-labelled octreotide scintigraphy in the diagnosis and management of non-iodine avid metastatic carcinoma of the thyroid
JA Christian, GJR Cook, C Harmer - British journal of cancer, 2003 - nature.com
Abstract Treatment of differentiated thyroid cancer is a success of modern medicine with the
use of radioiodine (131 I). However, a significant proportion of thyroid cancers may be non …
use of radioiodine (131 I). However, a significant proportion of thyroid cancers may be non …
[HTML][HTML] Ácido retinóico: uma terapia promissora para carcinoma treoideano desdiferenciado?
SM Coelho, R Corbo, A Buescu… - … de Endocrinologia & …, 2003 - SciELO Brasil
Carcinoma tireoideano é a neoplasia endócrina maligna mais freqüente. Aproximadamente
90% dos cânceres não-medulares da tireóide são classificados como diferenciados e …
90% dos cânceres não-medulares da tireóide são classificados como diferenciados e …
[HTML][HTML] Позитронно-эмиссионная томография с 18Г-фтордезоксиглюкозой в ракурсе современной диагностики, диспансерного наблюдения и лечения …
К Заплатников, К Менцель, М Диль… - Проблемы …, 2003 - probl-endojournals.ru
Аннотация Позитронно-эмиссионная томография с “F-фтордсзоксиг-люкозой (“F-ФДГ-
ПЭТ)-один из видов радионуклидных методов исследования, позволяющий определить …
ПЭТ)-один из видов радионуклидных методов исследования, позволяющий определить …
FDG PET and alternative imaging in the management of thyroid carcinoma
AM Al-Nahhas - Nuclear Medicine Review, 2003 - journals.viamedica.pl
Differentiated carcinoma of the thyroid are one of rare malignancies that is associated with
excellent prognosis. Follow-up with regular thyroglobulin assay and 131 I whole-body scan …
excellent prognosis. Follow-up with regular thyroglobulin assay and 131 I whole-body scan …
Nuklearmedizinische Diagnostik in der klinischen Onkologie
F Grünwald - Der Onkologe, 2003 - Springer
Die Entwicklung zahlreicher neuer Radiopharmaka hat zu einer zunehmenden Bedeutung
nuklearmedizinischer Verfahren in der onkologischen Diagnostik geführt. Daneben haben …
nuklearmedizinischer Verfahren in der onkologischen Diagnostik geführt. Daneben haben …
18F-Fluorodeoxyglucose positron emission tomography in terms of present-day diagnosis, follow-up, and treatment of differential thyroid cancer
K Zaplatnikov, C Menzel, M Diel… - Problems of …, 2003 - probl-endojournals.ru
Positron emission tomography with “F-fluorodsoxyglucose (“F-FDG-PET)-one of the types of
radionuclide research methods that can determine the increased glucose metabolism in …
radionuclide research methods that can determine the increased glucose metabolism in …
Erkrankungen endokriner Drüsen
K Mann, J Schopohl, S Petersenn, B Saller… - … Therapie in Klinik und …, 2003 - Springer
Zusammenfassung Der Hypothalamus koordiniert die Einflüsse des Zentralnervensystems
und ist durch Kontrolle der Hypophyse an der Steuerung fast des gesamten endokrinen …
und ist durch Kontrolle der Hypophyse an der Steuerung fast des gesamten endokrinen …